Filed: 8/14/2025ACC: 0000950123-25-008304
📋 What this filing means
FLAGSHIP PIONEERING, LLC filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $268.47M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$268.47M
Total AUM (reported)
43.46M
Total Shares
Allocation by class
COM$268.47M100.0%
Portfolio Concentration
Top 3$255.62M95.2%
4–10$12.84M4.8%
Top 3 weight
95.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 43.46M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
43.46M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other4
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings4
Rows:
Moderna Inc
DFNDShares4.63M
TypeSH
Market value$127.80M
47.60%
Sole
0.00
Shared
4.63M
None
0.00
Sana Biotechnology Inc
DFNDShares25M
TypeSH
Market value$68.26M
25.42%
Sole
0.00
Shared
25M
None
0.00
Foghorn Therapeutics Inc
DFNDShares12.67M
TypeSH
Market value$59.57M
22.19%
Sole
0.00
Shared
12.67M
None
0.00
Seres Therapeutics Inc
DFNDShares1.16M
TypeSH
Market value$12.84M
4.78%
Sole
0.00
Shared
1.16M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Moderna IncDFND | COM | 4.63M | SH | $127.80M 47.60% | 0.00 | 4.63M | 0.00 |
Sana Biotechnology IncDFND | COM | 25M | SH | $68.26M 25.42% | 0.00 | 25M | 0.00 |
Foghorn Therapeutics IncDFND | COM | 12.67M | SH | $59.57M 22.19% | 0.00 | 12.67M | 0.00 |
Seres Therapeutics IncDFND | COM | 1.16M | SH | $12.84M 4.78% | 0.00 | 1.16M | 0.00 |